Generic medicine

Mannitol 20% Infusion

Reviewed educational reference: what Mannitol is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Mannitol
Strength
20%
Dosage form
Infusion
Drug class
Osmotic Diuretic

Related products

No reviewed products are currently published for this generic.

Mannitol 20% Infusion is a concentrated solution containing Mannitol, which is a sugar alcohol that acts as a powerful osmotic diuretic. Unlike loop diuretics that act on ion transporters, Mannitol works by increasing the osmotic pressure of the glomerular filtrate. This prevents the reabsorption of water in the renal tubules, leading to increased urine output and the removal of excess fluid from the body tissues. It is primarily administered via intravenous infusion in hospital settings to manage critical conditions such as cerebral edema and acute ocular hypertension. Because it is not metabolized by the body, it is excreted almost entirely unchanged by the kidneys, making its efficacy highly dependent on renal function.

At a glance

Quick look

Mannitol 20% Infusion is an intravenous infusion containing 20% Mannitol.

How it works

It acts as an osmotic diuretic to remove excess fluid from tissues.

Who it is for

It is primarily used to reduce pressure in the brain and eyes.

Uses it for
Cerebral edemaAcute glaucomaIntracranial hypertensionAcute renal failureOliguriaNeurosurgical edema

Uses of Mannitol

  • Reduction of intracranial pressure in patients with cerebral edema.
  • Treatment of acute glaucoma to lower intraocular pressure.
  • Induction of osmotic diuresis in acute renal failure to maintain urine flow.
  • Prevention of brain herniation during neurosurgical procedures.
  • Reduction of interstitial edema in various systemic conditions.
  • Management of oliguria in specific acute kidney injury scenarios.

Benefits of Mannitol

Rapid Reduction of Pressure
Mannitol 20% Infusion provides a fast acting mechanism to pull fluid out of the brain and eye tissues. By creating an osmotic gradient, it draws water from the intracellular and interstitial spaces into the bloodstream, which quickly lowers pressure in the skull and the eye.

Prevention of Organ Damage
By promoting the excretion of water and electrolytes, Mannitol helps prevent permanent neurological damage caused by brain swelling. It also helps in flushing out metabolic waste products from the kidneys during periods of low urine output, which can support the recovery of renal function in specific acute settings.

Side effects of Mannitol

The use of Mannitol 20% Infusion can lead to several systemic complications. The most common issue is an electrolyte imbalance, particularly hypernatremia or hypokalemia, as the drug forces the excretion of water and salts. Some patients may experience nausea, vomiting, or a headache during the infusion. Because Mannitol initially expands the volume of the blood vessels, it can lead to fluid overload. This may manifest as pulmonary edema, where fluid accumulates in the lungs, causing shortness of breath. In rare cases, the rapid shift of fluids can cause a rebound effect, where water moves back into the brain tissue after the drug effect wears off, potentially worsening the edema. Local reactions at the injection site, such as redness or pain, are also possible.

Side effectHow commonHow severeWhat to do
Pulmonary EdemaUncommonSevereSlow the infusion rate.
HypernatremiaCommonModerateMonitor serum sodium levels.
Nausea and VomitingCommonMildAdminister slowly.

How to manage side effects

Pulmonary Edema

  • Stop infusion
  • Administer loop diuretics
  • Provide oxygen support
  • Consider mechanical ventilation

Hypernatremia

  • Adjust infusion rate
  • Administer hypotonic fluids
  • Monitor neurological status

Nausea and Vomiting

  • Give antiemetics
  • Slow the rate of infusion

How to use Mannitol

  • Mannitol 20% Infusion must be administered only via intravenous infusion.
  • The solution must be inspected for crystals before use. If crystals are present, the bottle should be warmed to dissolve them.
  • A sterile filter is often recommended during administration to ensure no undissolved particles enter the bloodstream.
  • The rate of infusion must be carefully controlled based on the patient's cardiac and renal status to avoid sudden volume overload.
  • Urine output and serum electrolytes must be monitored every few hours during the treatment course.

Special population advice

Kidney impairment

  • Avoid in patients with anuria.
  • Reduce dose and slow infusion rate in patients with low eGFR.
  • Monitor urine output hourly.

Liver impairment

  • No specific dose adjustment required.
  • Monitor for fluid overload if ascites is present.

Children

  • Dose based on body surface area or weight.
  • Strict monitoring of electrolytes to avoid rapid shifts.

Elderly

  • Start with lower doses due to decreased renal reserve.
  • Frequent monitoring of heart and lung sounds.

How Mannitol works

Mannitol is a pharmacologically inert substance that is filtered by the glomerulus but not reabsorbed by the renal tubules. It increases the osmolarity of the tubular fluid, which creates an osmotic pressure that opposes the reabsorption of water. This results in a large volume of dilute urine. Additionally, it draws water from the tissues into the vascular space, which increases blood volume and reduces edema in the brain and eyes.

What if you miss or exceed a dose?

If you miss a dose

Since Mannitol 20% Infusion is administered as an intravenous infusion in a clinical setting, the concept of a missed dose does not apply as it would for oral medication. The timing and duration are managed by healthcare professionals based on the patient's immediate physiological response.

In case of overdose

Overdose of Mannitol typically leads to severe hypervolemia and electrolyte disturbances. The most dangerous consequence is acute pulmonary edema due to the sudden increase in intravascular volume. Patients may also develop severe dehydration and hypernatremia as the osmotic diuresis continues unchecked. Treatment involves stopping the infusion immediately and using loop diuretics or dialysis to remove excess fluid and correct electrolyte levels.

Antidoteno specific antidote

Treatment is supportive and focuses on removing excess fluid.

Fluid Management
Stop the infusion immediately and assess for pulmonary edema.
Diuretic Therapy
Administer loop diuretics like furosemide to promote fluid removal.
Electrolyte Correction
Slowly correct sodium and potassium levels to avoid osmotic demyelination syndrome.
Renal Replacement
Use hemodialysis if the patient is in renal failure and fluid overload is severe.

Safety and precautions

When to avoid Mannitol

Do not take if you
  • Anuria

    Complete lack of urine production leads to dangerous fluid accumulation.

  • Active Intracranial Bleeding

    Can worsen the bleeding or increase pressure in the brain.

Use with caution
  • Severe Heart Failure

    Initial volume expansion can trigger acute heart failure.

  • Pulmonary Edema

    May worsen fluid accumulation in the lungs.

  • Severe Dehydration

    Can lead to extreme electrolyte imbalance and shock.

  • Renal Insufficiency

    Requires very slow infusion and constant monitoring of output.

Safety at a glance

AlcoholUse with caution

Avoid alcohol as it can contribute to dehydration and interfere with fluid balance.

PregnancyUse with caution

Use only if the benefit outweighs the risk to the fetus, under strict supervision.

BreastfeedingUse with caution

Consult a doctor as the safety of Mannitol in breast milk is not fully established.

DrivingSafe

This drug is given in hospitals, but it does not typically impair driving ability.

KidneyUnsafe

Do not use in patients with anuria or severe renal failure.

LiverSafe

Generally safe for liver patients, but monitor for fluid overload.

AllergyUse with caution

Check for hypersensitivity to any components of the infusion.

ChildrenUse with caution

Dose must be strictly calculated based on body weight and renal function.

ElderlyUse with caution

Use with extreme care due to higher risk of heart failure and renal impairment.

Interactions

With other medicines

Furosemide

Moderate

Changes the medicine’s effect

What can happen: Increased risk of severe dehydration and hypokalemia.

What to do: Monitor electrolytes and fluid intake closely.

Prednisolone

Moderate

Changes the medicine’s effect

What can happen: Corticosteroids cause sodium retention, opposing the diuretic effect.

What to do: Adjust dose of Mannitol or monitor edema more frequently.

Gentamicin

Major

Changes the medicine’s effect

What can happen: Increased risk of acute kidney injury, reducing Mannitol clearance.

What to do: Monitor renal function and reduce Mannitol dose.

With food and drink

  • High salt dietMinor

    Excess salt may counteract the diuretic effect of Mannitol.

  • Excessive fluid restrictionModerate

    Severe restriction of oral fluids can compound the risk of hypovolemia and acute dehydration during therapy.

If you have another condition

  • Congestive Heart Failure

    High risk of pulmonary edema due to intravascular volume expansion.

  • Diabetes Mellitus

    Generally safe, but monitor for osmotic changes in blood glucose.

Effect on laboratory tests

  • Serum Osmolality

    Increased

    The presence of Mannitol directly increases the measured osmolality of the blood.

  • Serum Sodium

    Variable

    Can cause either hypernatremia or hyponatremia depending on the rate of diuresis.

Quick tips

  • Always check the solution for crystals before starting the infusion.
  • Monitor the patient's breathing and lung sounds to detect early signs of pulmonary edema.
  • Ensure the patient has a functioning urinary catheter to accurately track urine output.
  • Do not use Mannitol 20% Infusion in patients who are completely unable to produce urine, as this will cause severe fluid overload.
  • Keep a close watch on serum sodium and potassium levels throughout the therapy.

Counselling points

  • AdministrationImportant

    You will receive this medication through a vein. It is important to stay in bed and be monitored by a nurse.

  • UrinationImportant

    You will likely urinate much more than usual. Please inform the staff if you stop producing urine.

  • Side EffectsImportant

    Tell your doctor immediately if you feel short of breath or have chest pain.

  • PurposeGood to know

    This medicine is being used to reduce the swelling in your brain or pressure in your eye.

Monitoring during treatment

Before starting

  • Serum electrolytes
  • Serum creatinine and BUN
  • Blood pressure
  • Lung auscultation

During treatment

  • every 4 hours: Check urine output and serum sodium levels
  • every 8 hours: Assess for signs of pulmonary edema

What is being watched

  • Urine volume
  • Serum osmolality
  • Potassium levels
  • Respiratory rate

Pharmacokinetics

Absorption
Not applicable as it is given intravenously.
Bioavailability
100%
Protein binding
0%
Volume of distribution
Limited to extracellular fluid.
Half-life
Not well defined, depends on renal clearance.
Metabolism
Minimal to none.
Excretion
Almost entirely excreted unchanged by the kidneys via glomerular filtration.
Onset / duration
Onset is rapid, usually within minutes of infusion.

Fact box

Chemical class
Sugar Alcohol
Habit forming
No
Therapeutic class
Diuretic
Action class
Osmotic Agent
Storage
Store Mannitol 20% Infusion at room temperature, typically between 15 and 30 degrees Celsius. Protect the infusion bottle from freezing and excessive heat.
ATC code
V01BB01
Pregnancy category
B

More information

Clinical Rationale for Selection

Clinicians typically choose Mannitol when they need a rapid and predictable reduction in intracranial or intraocular pressure. Unlike loop diuretics, which primarily target systemic fluid volume and sodium, Mannitol creates a powerful osmotic gradient. This gradient is essential for pulling water specifically from the brain parenchyma into the vascular space. In the case of acute glaucoma, it is often the first choice to prevent permanent optic nerve damage by quickly lowering the pressure inside the eye. The choice of Mannitol 20% Infusion over other agents is often based on the need for a non-metabolized substance that acts quickly and is cleared rapidly by the kidneys, provided the kidneys are functioning.

Comparison with Hypertonic Saline

Both Mannitol and hypertonic saline are used to treat cerebral edema, but they work differently. Hypertonic saline increases serum sodium, which pulls water out of the brain. However, it can lead to severe hyperchloremic acidosis and extreme hypernatremia. Mannitol is often preferred because it provides a dual benefit: it reduces brain swelling and simultaneously promotes a large volume of diuresis, which helps clear the systemic fluid load. However, Mannitol carries a higher risk of causing an initial increase in blood volume, which can be dangerous for patients with heart failure. The choice depends on the patient's sodium levels and their cardiac reserve.

Course of Treatment and Expectations

When a patient starts a course of Mannitol 20% Infusion, the initial phase is characterized by an expansion of the blood volume. This is the period where the drug pulls water from the tissues into the veins. Shortly after, the diuretic phase begins, where the kidneys excrete this excess water. A clinician expects to see a significant increase in urine output. If the urine output does not increase, the drug is not working and may be causing harm. Over the course of treatment, the goal is to maintain a stable intracranial pressure. Patients must be monitored for a rebound effect, where the brain may swell again if the osmotic gradient is dropped too quickly.

Common Misconceptions

A common misconception is that Mannitol is a form of sugar that will cause hyperglycemia in diabetic patients. In reality, it is a sugar alcohol that is not broken down for energy and does not raise blood glucose. Another misconception is that it can be used as a general diuretic for hypertension. Mannitol is not used for chronic blood pressure management because its effects are too potent and short lived, and it can cause severe electrolyte imbalances if used long term. Finally, some believe it is safe for all kidney patients, but in those with anuria, it is strictly contraindicated as it can lead to fatal pulmonary edema.

References

  1. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed
  2. FDA. Mannitol Injection Label.View sourceAccessed
  3. Baxter Viaflo. Mannitol solution for injection SmPC.View sourceAccessed
  4. Polifarma. Polifleks 20 Mannitol SPC.View sourceAccessed
  5. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th ed. McGraw Hill.Accessed

Frequently asked questions about Mannitol

Is Mannitol a sugar that will affect my blood glucose?

No, Mannitol is a sugar alcohol that is not metabolized by the body and does not significantly affect blood glucose levels.

Why is it necessary to warm the solution sometimes?

Mannitol can crystallize at cool temperatures. Warming ensures the crystals dissolve so the drug can be safely infused.

Can this drug be given as a bolus injection?

No, it must be given as a slow infusion to prevent sudden shifts in fluid and pressure that could damage organs.

What happens if the patient cannot urinate?

If a patient has anuria, Mannitol will stay in the blood and pull water into the vessels, leading to heart failure or pulmonary edema.

Does it work for all types of brain swelling?

It is used for vasogenic edema, but it may be less effective or even harmful in cases of cytotoxic edema.

Latest